EQS-News: Dermapharm Holding SE / Key word: Quarterly / Interim Statement/Quarter Results
Strong organic growth in core markets underscores resilience of Dermapharm Holding SE s.
EQS-News: Dermapharm Holding SE / Key word(s): 9 Month figures/Quarterly / Interim StatementDermapharm Holding SE builds on success in Q3 2023 15.11.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dermapharm Holding SE builds on success in Q3 2023 Consolidated r.
EQS-News: Dermapharm Holding SE / Key word: Half Year Results/Half Year Report
Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023.
EQS-News: Dermapharm Holding SE / Key word(s): Half Year Results/Half Year ReportDermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall 29.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Dermapharm Holding SE publishes H1 2023 finan.